Alterity Therapeutics (ATHE) Interest Coverage Ratio (2019 - 2024)
Alterity Therapeutics (ATHE) posted quarterly Interest Coverage Ratio of 2279.81 for Q4 2019.
Alterity Therapeutics (ATHE) Interest Coverage Ratio (2019 - 2024) Analysis & Trends
Alterity Therapeutics' Interest Coverage Ratio history runs 1 years deep, the most recent figure standing at 2279.81 for Q4 2019.
- In Q4 2019, Interest Coverage Ratio changed N/A year-over-year to 2279.81; the TTM figure through Dec 2019 stood at 13540.91 (changed N/A YoY), while the FY2025 annual figure was 1962.13, up 26.81% from the prior year.
- Interest Coverage Ratio for Q4 2019 stood at 2279.81.
- The five-year high for Interest Coverage Ratio was 2279.81 in Q4 2019, with the low at 2279.81 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 1.42 |
| 10 | Alterity Therapeutics | 49.04 Mn | 16.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 2,682.97 |
| Jun 30, 2023 | 3,060.69 |
| Jun 30, 2022 | 5,698.97 |
| Dec 31, 2019 | -2,279.81 |